Skip to main content

Table 1 The candidate stakeholder of MDR-TB

From: Identification and attribute analysis of key stakeholders who influence multidrug-resistant tuberculosis prevention and control in China

Candidate stakeholder

Approval proportion (%)

MDR-TB patients

100.0

Family members of MDR-TB patients

96.7

Neighbours of MDR-TB patients

100.0

Clinical department of county-level TB hospital

100.0

Clinical department of prefectural TB hospital

100.0

Administrative department of county-level TB hospital

100.0

Administrative department of prefectural TB hospital

100.0

County-level TB laboratory

90.0

Prefectural TB laboratory

95.0

Community health care facility

100.0

County-level CDC

100.0

Prefectural CDC

100.0

Provincial CDC

100.0

Department of Health Administration

96.7

Department of Medical Insurance

86.7

Department of Finance

83.3

Department of Social Welfare

83.3

The Red Cross and other charity organizations

80.0

TB Drug manufacturer

100.0

TB Testing reagent manufacturer

90.0

TB Testing equipment manufacturer

90.0

  1. MDR-TB Multidrug-resistant tuberculosis, TB Tuberculosis, CDC Centres for disease control and prevention